Canada markets closed

AC Immune SA (ACIU)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
2.5000+0.0200 (+0.81%)
At close: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 243.79M
Enterprise Value 134.52M
Trailing P/E 11.63
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)12.89
Price/Book (mrq)1.39
Enterprise Value/Revenue 9.09
Enterprise Value/EBITDA -2.60

Trading Information

Stock Price History

Beta (5Y Monthly) 1.01
52-Week Change 334.05%
S&P500 52-Week Change 323.10%
52 Week High 35.1400
52 Week Low 31.7800
50-Day Moving Average 33.0679
200-Day Moving Average 33.2122

Share Statistics

Avg Vol (3 month) 3182.21k
Avg Vol (10 day) 3213.5k
Shares Outstanding 598.9M
Implied Shares Outstanding 698.9M
Float 839.64M
% Held by Insiders 141.87%
% Held by Institutions 130.24%
Shares Short (Apr 15, 2024) 4509.36k
Short Ratio (Apr 15, 2024) 42.1
Short % of Float (Apr 15, 2024) 40.96%
Short % of Shares Outstanding (Apr 15, 2024) 40.52%
Shares Short (prior month Mar 15, 2024) 4582.97k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CHF.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-23.92%

Management Effectiveness

Return on Assets (ttm)-18.18%
Return on Equity (ttm)-32.90%

Income Statement

Revenue (ttm)14.8M
Revenue Per Share (ttm)0.17
Quarterly Revenue Growth (yoy)1,480,000.00%
Gross Profit (ttm)N/A
EBITDA -51.95M
Net Income Avi to Common (ttm)-54.23M
Diluted EPS (ttm)-0.7000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)103.05M
Total Cash Per Share (mrq)1.1
Total Debt (mrq)3.5M
Total Debt/Equity (mrq)2.18%
Current Ratio (mrq)9.22
Book Value Per Share (mrq)1.71

Cash Flow Statement

Operating Cash Flow (ttm)-60.41M
Levered Free Cash Flow (ttm)-42.11M